Neuralink, Elon Musk’s neurotechnology company, has received FDA breakthrough device designation for its new Blindsight implant. This device is designed to restore vision for people who have lost both eyes and their optic nerves. This special designation from the FDA speeds up the regulatory process, bringing Neuralink closer to starting human trials.
Blindsight is a major advancement in brain-computer interface technology. Unlike other methods, this implant bypasses damaged optic nerves and sends visual data directly to the brain. It aims to restore not just basic sight but also complex visual perception, offering a groundbreaking solution for those with severe vision loss.
Also read: SpaceX Engineer Sarah Gillis Becomes the First Person to Play Violin in Space
While this approval is an important step, Neuralink has not yet provided a timeline for clinical trials. Still, the potential of Blindsight offers hope, showing how advanced neurotechnology could change the future of vision restoration.
What do you think of the tech headlines today? Share your thoughts and stay tuned for breaking tech news.
Leave feedback about this